AtriCurevsMerck & Company

ATRC and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ATRC

AtriCure, Inc.

$54.91

Value $2.7B

-0.98%
ATRC's page

MRK

Merck & Company, Inc.

$132.59

Value $328B

-3.81%
MRK's page

AtriCure (ATRC) has a market value of $2.7B and Merck & Company (MRK) $328B. Over the last year, with dividends, ATRC moved +65.6% and MRK +41.6%. The P/E is 183.8 for ATRC and 133.6 for MRK. Dividend yield: ATRC none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ATRC$2.7B

    MRK$328B

    MRK is 120 times ATRC

  • Revenue, 12 months

    ATRC$590M

    MRK$67.4B

    MRK is 114 times ATRC

  • Net income, 12 months

    ATRC$15M

    MRK$2.5B

    MRK is 165 times ATRC

  • Operating margin

    ATRC2.9%

    MRK–

  • ROIC

    ATRC2.8%

    MRK3.9%

    1.1 points apart

  • P/E

    ATRC183.8

    MRK133.6

    ATRC is 1.4 times MRK

  • Dividend yield

    ATRC0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    ATRC-28.5%

    MRK+86.0%

    114.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ATRC-28.5%

MRK+86.0%

10020020222023202420252026
Returns by period
PeriodATRCWith dividendsMRKWith dividends
1 year since November 18, 2025+65.6%Price +65.6%+41.6%Price +37.5%
3 years since November 17, 2023+32.3%+9.8% a yearPrice +32.3%+42.8%+12.6% a yearPrice +30.3%
5 years since November 18, 2021-28.5%-6.5% a yearPrice -28.5%+86.0%+13.2% a yearPrice +59.7%
10 years since November 21, 2016+180.4%+10.9% a yearPrice +180.4%+202.6%+11.7% a yearPrice +123.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ATRCAtriCureMRKMerck & Company

Valuation

ATRCMRK
Valuation
Price$54.91$132.59
Market value$2.7B$328B
Enterprise value (EV)$2.6B$372B
P/E183.8133.6
P/E, 5-year median–14.8
P/B5.17.3
EV/EBIT154.978.1
Free cash flow yield1.9%4.5%

Results and growth

ATRCMRK
Results and growth
Revenue, 12 months$590M$67.4B
Net income, 12 months$15M$2.5B
Free cash flow, 12 months$53M$14.7B
Earnings per share, 12 months$0.30$0.98
Revenue growth, year on year14.9%1.3%
Revenue growth a year, past+21.0%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ATRCMRK
Margins and returns on capital
Gross margin76.7%71.8%
Operating margin2.9%–
Net margin2.5%3.6%
ROIC2.8%3.9%
ROE3.0%5.2%

Balance sheet

ATRCMRK
Balance sheet
Cash$187M$9.7B
Total debt$97M$53.8B
Net debt / EBITDA-3.35.7
Interest cover3.0×2.4×

Dividends and buybacks

ATRCMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.6%
Shareholder yield–4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ATRC or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, AtriCure or Merck & Company?

By market value, Merck & Company ($328B) is about 119.9 times AtriCure ($2.7B), at today's prices.

How did ATRC and MRK stock do over the last 10 years?

Since November 21, 2016, ATRC's price moved +180.4% and MRK's +123.0%. With dividends: ATRC +180.4% (+10.9% a year), MRK +202.6% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ATRC or MRK?

The dividend yield at today's price is none for AtriCure and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ATRC and MRK?

At today's price, the P/E is 183.8 for ATRC and 133.6 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AtriCure or Merck & Company?

Over the last twelve months, the net margin was 2.5% for AtriCure and 3.6% for Merck & Company, and the operating margin 2.9% and –. Revenue was $590M and $67.4B.

Which is the better investment, AtriCure or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.